Comparing the Accuracy of POC Creatinine/eGFR vs. Measured GFR for Evaluating Kidney Disease
Date: Thursday, July 08, 2021 & July 22, 2021
Time: 01:00 PM Eastern Daylight Time
Chronic kidney disease is rising rapidly in low- and middle-income countries due to limited resources and is associated with high morbidity and mortality. Serum creatinine and estimation of glomerular filtration rate (eGFR) are critical diagnostic tools for kidney disease, yet access to centralized laboratory services remains limited in primary care resource-limited settings. In this webinar, Dr. Currin discusses the results of a large, 670 patient study in a rural South African population evaluating point-of-care (POC) technologies for serum creatinine/eGFR measurement and comparing their performance to a gold standard measurement using iohexol measured GFR (mGFR).
Dr. Begos will share Nova Biomedical’s commitment to a close relationship with researchers, clinicians, and government health agencies to improve care for patients with kidney disease worldwide.
Sean Currin, MD
Department of Chemical Pathology
University of Witwatersrand and National Health Laboratory Service
Dennis Begos, MD, FACS, FACRS
Associate Medical Director, Medical and Scientific Affair
Nova Biomedical